These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2507135)
61. The enzyme-activated irreversible inhibitor of ornithine decarboxylase, DL-alpha-difluoromethylornithine: a chemopreventive agent. Verma AK Prev Med; 1989 Sep; 18(5):646-52. PubMed ID: 2515533 [TBL] [Abstract][Full Text] [Related]
62. Heterogeneous survival and cell kinetics responses of human astrocytoma clones to alpha-difluoromethylornithine in vitro. Barranco SC; Ford PJ; Townsend CM Invest New Drugs; 1989 Jul; 7(2-3):155-61. PubMed ID: 2507473 [TBL] [Abstract][Full Text] [Related]
63. Cell cycle kinetics responses of human stomach cancer cells to reduction in polyamine levels by treatment with alpha difluoromethylornithine in vitro. Barranco SC; Ford PJ; Townsend CM Invest New Drugs; 1986; 4(4):347-57. PubMed ID: 3108188 [TBL] [Abstract][Full Text] [Related]
64. Histone deacetylase-10 liberates spermidine to support polyamine homeostasis and tumor cell growth. Stewart TM; Foley JR; Holbert CE; Klinke G; Poschet G; Steimbach RR; Miller AK; Casero RA J Biol Chem; 2022 Oct; 298(10):102407. PubMed ID: 35988653 [TBL] [Abstract][Full Text] [Related]
65. Changes in blood polyamine levels in human acute pancreatitis. Jin HT; Räty S; Minkkinen M; Järvinen S; Sand J; Alhonen L; Nordback I Scand J Gastroenterol; 2009; 44(8):1004-11. PubMed ID: 19444716 [TBL] [Abstract][Full Text] [Related]
67. A phase II study of alpha-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma. Meyskens FL; Kingsley EM; Glattke T; Loescher L; Booth A Invest New Drugs; 1986; 4(3):257-62. PubMed ID: 3102397 [TBL] [Abstract][Full Text] [Related]
68. Polyamine inhibitors for treatment of feline oral squamous cell carcinoma: a proof-of-concept study. Lewis JR; O'Brien TG; Skorupski KA; Krick EL; Reiter AM; Jennings MW; Jurney CH; Shofer FS J Vet Dent; 2013; 30(3):140-5. PubMed ID: 24371920 [TBL] [Abstract][Full Text] [Related]
69. Influence of cyclosporin A and alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, on two rodent T-cell cancers in vivo. Smart LM; MacLachlan G; Wallace HM; Thomson AW Int J Cancer; 1989 Dec; 44(6):1069-73. PubMed ID: 2514149 [TBL] [Abstract][Full Text] [Related]
70. Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas. Raj KP; Zell JA; Rock CL; McLaren CE; Zoumas-Morse C; Gerner EW; Meyskens FL Br J Cancer; 2013 Feb; 108(3):512-8. PubMed ID: 23340449 [TBL] [Abstract][Full Text] [Related]
71. Phase I study of combined alpha interferon, alpha difluoromethylornithine (DFMO), and doxorubicin in advanced malignancy. Ganju V; Edmonson JH; Buckner JC Invest New Drugs; 1994; 12(1):25-7. PubMed ID: 7960601 [TBL] [Abstract][Full Text] [Related]
72. Nutritional parameters affecting erythrocyte polyamine levels in cancer patients. Ota DM; Nishioka K; Foulkes M; Grossie VB J Clin Oncol; 1984 Oct; 2(10):1157-64. PubMed ID: 6436445 [TBL] [Abstract][Full Text] [Related]
73. Phase I evaluation of intravenous difluoromethylornithine--a polyamine inhibitor. Maddox AM; Keating MJ; McCredie KE; Estey E; Freireich EJ Invest New Drugs; 1985; 3(3):287-92. PubMed ID: 3934106 [TBL] [Abstract][Full Text] [Related]
74. In vivo manipulation of L1210 cell cycle phase distribution with alpha-difluoromethylornithine, 4-amidinoindan-1-one 2'-amidinohydrazone and N1-acetylspermine. Dorhout B; Ferwerda H; Kingma AW; de Hoog E; Muskiet FA Biochim Biophys Acta; 1998 Jun; 1381(1):89-94. PubMed ID: 9659375 [TBL] [Abstract][Full Text] [Related]
75. Continuous infusion of DL-alpha-difluoromethylornithine and improved efficacy against a rat model of Pneumocystis carinii pneumonia. Chin K; Merali S; Sarić M; Clarkson AB Antimicrob Agents Chemother; 1996 Oct; 40(10):2318-20. PubMed ID: 8891137 [TBL] [Abstract][Full Text] [Related]
76. Difluoromethylornithine rebalances aberrant polyamine ratios in Snyder-Robinson syndrome: mechanism of action and therapeutic potential. Stewart TRM; Foley JR; Holbert CE; Khomutov MA; Rastkari N; Tao X; Khomutov AR; Zhai RG; Casero RA bioRxiv; 2023 Apr; ():. PubMed ID: 37034775 [TBL] [Abstract][Full Text] [Related]
77. Mononuclear cell polyamine content associated with myeloid maturation in patients with leukemia during administration of polyamine inhibitors. Maddox AM; Keating MJ; Freireich EJ; Haddox MK Invest New Drugs; 1989 Jul; 7(2-3):119-29. PubMed ID: 2507470 [TBL] [Abstract][Full Text] [Related]
78. A phase I study of hepatic arterial infusion using difluoromethylornithine. Lipton A; Harvey HA; Glenn J; Weidner WA; Strauss M; Miller SE; Taylor JB; White-Hershey D; Barlow JL Cancer; 1989 Feb; 63(3):433-7. PubMed ID: 2492203 [TBL] [Abstract][Full Text] [Related]
79. Erythrocyte polyamine levels during intravenous feeding of patients with colorectal carcinoma. Ota DM; Nishioka K; Grossie B; Dixon D Eur J Cancer Clin Oncol; 1986 Jul; 22(7):837-42. PubMed ID: 3095122 [TBL] [Abstract][Full Text] [Related]
80. Difluoromethylornithine and leukocyte interferon: a phase I study in cancer patients. Talpaz M; Plager C; Quesada J; Benjamin R; Kantarjian H; Gutterman J Eur J Cancer Clin Oncol; 1986 Jun; 22(6):685-9. PubMed ID: 3091371 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]